The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Wolseley Sold Amid Job Cuts, No Extra Payout

Tue, 27th Sep 2016 09:33

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.
----------
FTSE 100 - WINNERS
----------
Carnival, up 2.8%. The cruise ship operator on Monday reported growth in profit in the third quarter of its financial year, and said it is on track to deliver 25% earnings growth in the full year. Carnival said its pretax profit in the three months ended August 31 grew to USD1.47 billion from USD1.25 billion in the same period the year before, as revenue rose to USD5.10 billion from USD4.88 billion. It said this was its strongest ever quarterly earnings. Carnival said revenue during the peak summer season was bolstered by strong performances in both its North American and European brands, and across all major deployments including the Caribbean, Alaska and Europe. Shore Capital was impressed with the company's outlook statement, saying it was "encouraging". Fellow travel stock TUI Group was up 0.9%.

Sky, up 1.0%. The pay-TV company was upgraded to Buy from Hold by Keppler Cheuvreux, according to traders.

United Utilities Group, up 1.0%. The water company said trading in the half-year to the end of September has been in line with its expectations and said underlying profit for the period will be slightly higher due to lower spending. Revenue for the half will be slightly lower year-on-year, the group said, reflecting the accounting impact of the Water Plus joint venture that it sealed with blue-chip peer Severn Trent in June. Underlying operating profit for the first half will be marginally higher year-on-year, however, due to slightly lower infrastructure renewal spending, though this is due to increase in the second half.
----------
FTSE 100 - LOSERS
----------
Wolseley, down 3.4%. The building materials supplier reported increases in both profit and revenue during its recently completed financial year, though it noted there will be job cuts in its UK division. Wolseley reported pretax profit of GBP727.0 million for the year ended June 30, up from GBP508.0 million a year earlier, and driven by a 9.0% rise in revenue to GBP14.43 billion from GBP13.30 billion. The strong revenue growth came largely within Wolseley's US division, where there were good US residential and commercial markets. The group announced a turnaound and re-positioning strategy in its UK division, with 80 branches and one distribution centre to be closed, resulting in up to 800 job losses. Liberum said the start to the new financial year was slower than expected. Davy noted that, beyond the US, there is little growth or opportunity to generate excitement on Wolseley. Moreover, "failure to return excess cash for the first year in four is, however, likely the real culprit for investor displeasure," Accendo Markets analyst Mike Van Dulken added. Fellow builders' merchant Travis Perkins was down 2.4%.
----------
FTSE 250 - WINNERS
----------
Card Factory, up 2.3%. The greeting card and gifts retailer reported growth in profit in the first half of its financial year on higher revenue and it said it is on track to meet full-year expectations. The company said its pretax profit in the six months to the end of July rose to GBP27.0 million from GBP24.0 million the year before, as revenue grew to GBP169.2 million from GBP161.4 million. Card Factory said its results were boosted by improvements in the quality and range of both card and non-card categories, with good ongoing growth in average spend, helping like-for-like sales to grow by 0.2% year-on-year. It did say, however, that sales growth from its stores was slightly lower than normal due to softer footfall. Total sales were also boosted by the opening of 34 new stores, taking the total estate to 848 stores.

Indivior, up 2.3%. The drugmaker said 35 US states and the District of Colombia now have filed a civil complaint alleging violations of state and federal antitrust and consumer protection laws. Indivior shares had fallen on Friday after the company had highlighted the plans by the states to file the complaint. Indivior said the complaint alleges that the company switched its Suboxone Film opioid addiction treatment from a tablet to a film in order to prevent or delay the introduction of generic alternatives. "The company continues to take these allegations seriously, intends to defend this and other related actions, and will continue to cooperate with the relevant US government agencies in their investigations of the company," Indivior said.

CYBG, up 2.0%. Goldman Sachs started coverage of the challenger bank with a Neutral rating. The investment bank cut UK peer Metro Bank to Sell from Neutral. Metro Bank shares were down 1.9%.
----------
FTSE 250 - LOSERS
----------
Mitie Group, down 2.6%. Investec cut the facilities management and outsourcing firm to Hold from Buy after its profit warning last week. Mitie had said lower rates of economic growth in the UK and changes to worker legislation has hit trading. Mitie had warned in its annual results in May on the introduction of the National Living Wage, effectively a minimum wage for over-25s in the UK. "Our forecasts are reduced modestly at the top line (FY17 -2.4%), with profit falling more significantly (adjusted [earnings-per-share] - 21.7% for FY17)," said Investec analysts.
----------
MAIN MARKET AND AIM - WINNERS
----------
Immedia Group, up 34%. The in-store music and communications solutions provider said it has signed a new three-year contract with "a major UK retailer", which it did not name. The company said further information about the deal will be provided when client confidentiality is lifted. No financial details on the agreement were disclosed. Immedia had first announced the potential contract back in August. Immedia noted the contract had been won following its statement in August that its contract with Top Shop owner Arcadia Group will expire at the end of 2016.

Redx Pharma, up 20%. The drug development firm said it has discovered a series of compounds which could create the first novel class of broad-spectrum antibiotics in more than three decades. The company said its scientists have identified novel bacterial topoisomerase inhibitors which function as antibiotics against drug resistant Gram-negative bacteria. Further testings has shown the company has discovered compounds which could prove highly-effective against drug resistant strains of Gram-negative bacteria, which may have implications for drug-resistant infections such as e.coli and pseudomonas, which in turn are responsible for pneumonia, blood poisoning, and urinary tract and abdominal infections.
----------
MAIN MARKET AND AIM - LOSERS
----------
Greka Drilling, down 21%. The oil and gas drilling company reported a wider pretax loss for the first half of 2016 following a slump in revenue as it struggles against weak activity levels in the oil and gas market. Greka said it made a pretax loss of USD5.5 million in the half-year to the end of June, compared to USD4.8 million a year before, as a substantial fall in costs offset revenue declining 78% to USD2.6 million from USD11.9 million. Greka said, in line with the guidance it gave earlier in the year, activity levels were "very limited" in the first half. It drilled a total of 10 wells in the first half, compared to 28 in the comparable period in 2015.

Cellcast, down 17%. The chat and adult interactive channel operator said pretax profit shrank in the first half of 2016 on flat revenue but a weaker gross margin. Cellcast said pretax profit for the half-year to the end of June was GBP77,989, down 69% from GBP255,642 a year prior. Revenue slipped slightly to GBP5.7 million from GBP5.8 million, but its gross margin dropped to 6.6% from 11.0% a year before. The company said its UK interactive broadcast revenue declined to GBP5.3 million from GBP5.6 million a year before and revenue from its newly-launched overseas gaming services failed to offset the decline. Cellcast said it does not anticipates a near-term recovery for its core interactive TV business, but does intend launching a new cable TV platform and new paid-for online content in order to try to arrest the slump.

Universe Group, down 12%. The point-of-sale, payment and online loyalty systems provider issued a profit warning on Tuesday due to delays experienced with the roll out of new products. Universe Chairman Robert Goddard said its new products were successfully piloted with its customers in the first half of 2016, but there will be a delay in starting the full-scale deployments due to issues experienced as the products are made ready for client requirements. In particular, this will effect the roll-out of new products with three large customers, and that trio will now be launched in 2017 rather than in 2016, as originally envisaged. Due to this, Goddard said Universe's financial performance for 2016 will be "slightly below" the company's expectations, though it remains confident on its outlook given its robust pipeline.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
9 Sep 2020 12:26

Redx signs new collaboration deal with Jazz Pharmaceuticals

(Sharecast News) - Drug discovery and development company Redx Pharma has signed a new research collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates for two cancer targets on the Ras/Raf/MAP kinase (MAPK) pathway.

Read more
5 Aug 2020 15:11

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

Read more
4 Aug 2020 13:58

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

Read more
4 Aug 2020 08:45

Redx Pharma surges on AstraZeneca licensing agreement

(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.

Read more
1 Jul 2020 17:15

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Read more
30 Jun 2020 14:47

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

Read more
18 May 2020 14:39

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

Read more
1 May 2020 14:36

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
9 Apr 2020 18:38

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Read more
2 Apr 2020 18:32

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Read more
30 Mar 2020 17:04

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Read more
13 Mar 2020 10:58

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

Read more
13 Mar 2020 10:31

Redx shares surge on possible cash offer from Yesod

(Sharecast News) - Drug discovery and development company Redx Pharma has received a further private approach from Yesod Bio-Sciences, it announced on Friday, that could lead to a possible cash offer for the entire issued and to be issued share capital of the company, at a price of 15p per share.

Read more
13 Mar 2020 09:26

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.